771510-15-7

Basic information

• Product Name: 2-forMyl-3-Methylbutanenitrile
• Synonyms: 2-forMyl-3-Methylbutanenitrile
• CAS NO: 771510-15-7
• Molecular Formula: C₆H₉NO
• Molecular Weight: 111.14176
• Mol File: 771510-15-7.mol
• Article Data: 23

Chemical Properties

• Boiling Point: 174.1±23.0 °C(Predicted)
• Appearance: /
• Density: 0.933±0.06 g/cm3(Predicted)
• CAS DataBase Reference: 2-forMyl-3-Methylbutanenitrile(CAS DataBase Reference)
• NIST Chemistry Reference: 2-forMyl-3-Methylbutanenitrile(771510-15-7)
• EPA Substance Registry System: 2-forMyl-3-Methylbutanenitrile(771510-15-7)

Safety Data

• Hazardous Substances Data: 771510-15-7(Hazardous Substances Data)

Usage

General Description

2-ForMyl-3-Methylbutanenitrile is a chemical compound with the molecular formula C8H13N. It is a colorless liquid with a fruity odor and is commonly used in the production of fragrances and flavors. 2-forMyl-3-Methylbutanenitrile is also known by the trade name "Furaneol" and is found naturally in a variety of fruits, including strawberries, raspberries, and tomatoes. It is often used in the food industry to add a sweet, caramel-like flavor to products. In addition to its use in food and fragrance production, 2-ForMyl-3-Methylbutanenitrile is also used in the manufacture of pharmaceuticals and in chemical research.

Upstream product

• 590-86-3 isovaleraldehyde 
• 1059526-52-1 3-methyl-2-(nitromethyl)butanenitrile 
• 625-28-5 Isovaleronitrile 
• 109-94-4 formic acid ethyl ester 
• 74067-77-9 α-iodo-isovaleraldehyde 
• 151-50-8 potassium cyanide 

Downstream Products

• 151521-49-2 4-isopropyl-1 H-pyrazol-5-amine 
• 718633-43-3 2-(aminomethyl)-3-methyl-1-butanol 
• 771510-32-8 5,7-dichloro-3-iso-propyl-pyrazolo[1,5-a]pyrimidine 
• 1092443-98-5 benzyl-(5-chloro-3-iso-propylpyrazolo[1,5-a]pyrimidin-7-yl)-amine 
• 1092444-33-1 benzyl (5-chloro-3-isopropylpyrazolo[1,5-a]pyrimidin-7-yl)carbamic acid tert-butyl ester 
• 1256288-44-4 tert-butyl benzyl(5-((6-((tert-butoxycarbonyl)amino)hexyl)amino)-3-isopropylpyrazolo[1,5-a]pyrimidin-7-yl)carbamate 
• 1092444-48-8 tert-butyl (R)-benzyl-{5-[1-(tert-butyl-dimethylsilyloxy)-9-(6-fluoropyridin-3-yl)-non-2-ylamino]-3-isopropyl-pyrazolo[1,5-a]pyrimidin-7-yl}carbamate 
• 1092444-38-6 [(R)-6-{7-[tert-butoxycarbonyl-(2-fluoro-benzyl)-amino]-3-isopropyl-pyrazolo[1,5-a]pyrimidin-5-ylamino}-7-(tert-butyl-dimethyl-silanyloxy)-heptyl]-carbamic acid tert-butyl ester 
• 1092444-49-9 tert-butyl benzyl-((R)-5-(9-(6-fluoropyridin-3-yl)-1-hydroxynonan-2-ylamino)-3-isopropylpyrazolo[1,5-a]pyrimidin-7-yl)carbamate 
• 1092444-39-7 [(R)-6-{7-[tert-butoxycarbonyl-(2-fluoro-benzyl)-amino]-3-isopropyl-pyrazolo[1,5-a]pyrimidin-5-ylamino}-7-hydroxy-heptyl]-carbamic acid tert-butyl ester 
• 1092444-62-6 tert-butyl benzyl(3-isopropyl-5-(2,2,3,3,10,10,11,11-octamethyl-4,9-dioxa-3,10-disiladodecan-6-ylamino)pyrazolo[1,5-a]pyrimidin-7-yl)carbamate 
• 1092444-52-4 tert-butyl benzyl(5-(((2S,3R)-1-((tert-butyldimethylsilyl)oxy)-3,4-dihydroxybutan-2-yl)amino)-3-iso-propylpyrazolo[1,5-a]pyrimidin-7-yl)carbamate 
• 1092444-51-3 tert-butyl benzyl(5-(((2S,3S)-1-((tert-butyldimethylsilyl)oxy)-3,4-dihydroxybutan-2-yl)amino)-3-iso-propylpyrazolo[1,5-a]pyrimidin-7-yl)carbamate 
• 1092444-61-5 tert-butyl 5-(3-(tert-butyldimethylsilyloxy)propylamino)-3-isopropylpyrazolo[1,5-a]pyrimidin-7-yl(2-fluorobenzyl)carbamate 

Relevant articles and documents

CDK KINASE INHIBITOR, PREPARATION METHOD THEREFOR, PHARMACEUTICAL COMPOSITION, AND APPLICATION

Disclosed in the present invention are a CDK kinase inhibitor, a preparation method therefor, a pharmaceutical composition, and an application. The present invention provides a compound as represented by formula I-a, a cis-trans isomer thereof, a pharmaceutically acceptable salt thereof, a solvate of the pharmaceutically acceptable salt thereof, a tautomer thereof, or a polymorph thereof. The compound of the present invention has good CDK7 inhibitory activity, cell activity, and tumor growth inhibitory activity.

CDK inhibitor based on organic arsine as well as preparation method and application of CDK inhibitor

The invention provides a CDK inhibitor based on organic arsine as well as a preparation method and application of the CDK inhibitor. Specifically, the invention providese compounds of Formula I, or stereoisomers or tautomers thereof, or pharmaceutically acceptable salts, hydrates or solvates thereof; and the invention also discloses a preparation method and application thereof. Definitions of allgroups in the formula are shown in the specification.

HSP90 INHIBITORS AND USES THEREOF

Herein is described the design and synthesis of resorcylate aminopyrazole compounds. These compounds show broad, potent and fungal-selective Hsp90 inhibitory activity. These compounds also find use in treating Hsp90 related deseases.